Weigh Risks and Benefits of COVID-19 Response, Advises

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
115
Weigh Risks and Benefits of COVID-19 Response, Advises Association of American Physicians and Surgeons (AAPS)

TUCSON, Ariz., March 21, 2020 (GLOBE NEWSWIRE) -- A new group called US Healthcare Providers for Federal Action Against COVID-19 has launched a petition on change.org calling for an immediate national quarantine . 

At its March 20 board of directors meeting, the Association of American Physicians and Surgeons (AAPS) recommended rational consideration of the risks and benefits of responses to this pandemic.

Critically important is the right to try safe treatments without being obstructed by the FDA. AAPS directors noted that FDA approved a potential cure for COVID-19 half a century ago. Chloroquine (CQ) and hydroxychloroquine (HCQ) have been widely used against malaria, lupus, and rheumatoid arthritis.

Physicians can legally prescribe CQ and HCQ now, AAPS directors stated, and independent physicians are doing so. Recent studies from France and China report excellent results. Research on the effects of CQ on coronavirus and other viruses—and the body’s destructive cytokine response— dates back to 2003 . Employed physicians may be unwilling to prescribe CQ or HCQ because of pressure from insurers or hospitals, AAPS has observed, as they do not have FDA approval for this specific indication. Adding indications to a drug label requires costly, time-consuming studies. Thus, a large proportion of all prescriptions are written for “off-label” uses.

“Without this medical freedom, physicians could not provide the best care, and some diseases would have no treatment at all,” states AAPS. Besides dramatically reducing symptoms, these drugs are stated to quickly reduce infectivity, especially when combined with the common antibiotic azithromycin.

Supplies of these formerly cheap and abundant drugs are running short, some directors reported, though manufacturers are said to be ramping up production. One company claimed, according to a Texas physician, to be able to produce vast quantities at pennies per dose within a week—if it could buy ingredients.

“If we withhold treatment while waiting for a vaccine, which may never happen, or a new, very costly drug, thousands could unnecessarily wind up on a ventilator—or die,” AAPS directors said.

Side effects of the drugs include severe rashes, retinal or kidney damage, hearing loss, tinnitus, and balance problems. Fatal heart rhythms could occur in patients with a certain rare EKG finding—also a possibility with azithromycin. These events are rare, in the experience of AAPS specialists, but must be considered in prescribing.

Because of the government’s lockdown, hundreds of thousands have already lost their jobs in California alone. Deaths from impoverishment and chaos could exceed those that might—or might not—be prevented by indiscriminate quarantine.

“We must not kill the economy while refusing to recruit an old ally against the disease,” AAPS states.

The Association of American Physicians and Surgeons (AAPS) has represented physicians of all specialties since 1943.

Jane M. Orient, M.D., (520) 323-3110, janeorientmd@gmail.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ROBOTWORLD 2026: AI Reshapes Industrial Horizons

Updated Category News Views 20

A Grand Gathering of Robotics Minds Walking into KINTEX, Seoul's suburban behemoth of an exhibition center, you'll find a buzz that rivals the excitement of a stock floor on earnings day. It's ROBOTWORLD 2026, a stage set for tech titans and ambitious startups alike, all throwing in their chips on AI and robotics. From November 4th to 7th, 402 companies hailing from 17...

Continue Reading
Synova Global Taps Eventus for Top Trade Surveillance

Updated Category News Views 163

Synova and Eventus: A Powerful Partnership If you've ever traded a share or two, you know the name of the game is risk management. Step into Synova Global's latest move, and you'll see a gamble worth watching closely. This time around, Synova has tapped Eventus to bring their Validus trade surveillance platform into the fold. Now, Eventus and its star player, Validus,...

Continue Reading
Are Insider Deals Jipping OPCH, PTC, RXO Shareholders?

Updated Category News Views 40

Let's Scrutinize These Big Transactions Alright, let's cut to the chase. We're seeing some big moves from Option Care Health, PTC Inc., and RXO Inc. that have us wondering if the shareholders are getting the short end of the stick. That's what Halper Sadeh LLC seems to think. They're rolling up their sleeves, investigating whether these companies have tossed aside their...

Continue Reading
Hemp Gift Guide Showcases Calm and Rest with CBD

Updated Category News Views 108

Digging Into Holiday Wellness Gifts In this age where peace can feel as elusive as a pot of gold, gifting something that whispers serenity and comfort has its charm. Enter Rare Cannabinoid Company, a Hawaii-based brand, weaving from their cannabinoid blend a holiday gift guide designed to infuse calm into the season's chaos. Now, that's something. A Unique Take on Holiday...

Continue Reading
Alfa Laval's Market Outlook: Strategic Plans Ahead

Updated Category News Views 32

Alfa Laval's Vision for the Future Alfa Laval is gearing up for a dynamic Capital Markets Day on November 18, 2026. The Swedish engineering giant, renowned for heat transfer, separation, and fluid handling solutions, is setting the stage to outline bold strategies and ambitious targets. Investors should pay attention, as the company's roadmap charts a course towards a SEK...

Continue Reading
PG&E, Edison Push Liability Cap Amid Firestorm

Updated Category News Views 93

The Thanksgiving Playbook Nobody Wanted Sacramento's corridors are buzzing with electric tension. And why? It's not some trivial turkey drama but a simmering scandal over two utility giants trying to sneak a liability cap into law faster than you can ask for a second slice of pumpkin pie. PG&E and Edison have a little secret—a covert strategy to limit shareholder...

Continue Reading
Pyramid Pharma Takes On 13th Blood Cancer Therapy Product

Updated Category News Views 78

Pyramid Pharma: Breaking New Ground in Blood Cancer Treatments There's a new player making waves in the battle against rare blood cancers: Pyramid Pharma Services. This U.S.-based contract development and manufacturing organization is stepping up its game by finessing a cartridge-based product designed to treat those rare and tricky blood maladies. The canvas? A...

Continue Reading
Baidu Faces Fraud Allegations: What Investors Should Know

Updated Category News Views 34

Trouble on the Horizon for Baidu Shareholders If you've got a pulse in the world of stock trading, you've likely caught wind of the storm brewing over at Baidu, Inc. (NASDAQ: BIDU). We're talking some heavy-duty allegations of securities fraud, and a class action lawsuit that's got investors scrutinizing their portfolios like never before. The lawsuit's been filed in the...

Continue Reading
Svea Mining Taps DNB Carnegie to Boost Liquidity

Updated Category News Views 54

Mining Moves and Market Churn Dusted off my boots and took a gander at Svea Mining AB. They’re a Swedish outfit that's rustling up some gold, copper, and silver out in the wilds of Northern Sweden. Now, they've got DNB and Carnegie stepping in as liquidity providers. Let me chew on this for a minute—why does a miner need a liquidity provider, you ask? It’s all about...

Continue Reading
Instanodes Tackling Quantum Threats in Blockchain

Updated Category News Views 172

Diving Into Quantum Cryptography for Blockchain Instanodes is throwing down the gauntlet for the blockchain crowd as the field of quantum computing edges ever closer to unsettling the cryptographic order. This company's latest play? Post-quantum account engineering for major players like Ethereum and Solana. And it's not just tinkering—they're giving the status quo a...

Continue Reading

Top 5 Most Recently Viewed Articles

China's Ambitious Strategies for Economic Growth and Opening Up

Updated Category News Views 305

China's Vision for Economic Growth and Openness In recent discussions, major economic strategies unveiled by China's leaders emphasize high-standard opening up as a core element to drive high-quality development. As the nation refines its approach towards modernization, this focus is paramount in shaping the future economic landscape. The Hainan Free Trade Port: A New Era...

Continue Reading
Callan's New Direction with Research Visionary Pete Keliuotis

Updated Category News Views 34

New Leadership Sparks a Strategic Shift at Callan Out of the blue, Callan's latest move caught my eye, like spotting a wild card in a game of poker. Appointing Pete Keliuotis to head their Public and Private Markets Research isn't just a reshuffle; it's a bet on a vision for the future of investment consulting. The announcement came on June 10, 2026, with the change set...

Continue Reading
AEWIN Unveils Innovative Edge Computing Server for AI Solutions

Updated Category News Views 171

AEWIN Introduces the BAS-6101A Edge Computing Server AEWIN is set to capture attention at the upcoming trade show with its state-of-the-art BAS-6101A, a high-density edge computing server. This server, driven by a single AMD Zen5/Zen4c/Zen4 EPYC processor, is specifically designed for real-time and compute-intensive edge applications. The BAS-6101A stands out by offering...

Continue Reading
Revolutionizing Energy: The Future of Hydration and Vitality

Updated Category News Views 270

Revolutionizing Energy with Liquid I.V.® Energy drinks have long been dominated by products that often leave users feeling jittery, leading to sugar crashes that leave them drained. However, Liquid I.V.® is breaking the mold with its latest innovation: the Energy Multiplier® Sugar-Free. This new product is designed with a unique hydration-first approach, blending...

Continue Reading
Weyerhaeuser Company Announces New Quarterly Dividend Plans

Updated Category News Views 159

Weyerhaeuser Company Declares New Dividend on Common Shares Weyerhaeuser Company (NYSE: WY) has recently announced its decision regarding the upcoming quarterly dividend for its common stock. The board of directors has declared a base cash dividend of $0.21 per share. This dividend is a part of the company's ongoing efforts to return value to its shareholders and is...

Continue Reading